Novavax
NVAX
#5751
Rank
HK$8.74 B
Marketcap
HK$53.79
Share price
0.73%
Change (1 day)
-16.71%
Change (1 year)

Novavax (NVAX) - Cash on Hand

Cash on Hand as of September 2025 : HK$5.93 Billion

According to Novavax's latest financial reports the company has HK$5.93 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novavax - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$7.16 B61.41%
2023-12-31HK$4.44 B-57.49%
2022-12-31HK$10.44 B-11.59%
2021-12-31HK$11.81 B114.33%
2020-12-31HK$5.51 B797.92%
2019-12-31HK$0.61 B-14.92%
2018-12-31HK$0.72 B-41.29%
2017-12-31HK$1.22 B-32.7%
2016-12-31HK$1.82 B2.14%
2015-12-31HK$1.78 B37.15%
2014-12-31HK$1.30 B26.33%
2013-12-31HK$1.03 B201.79%
2012-12-31HK$0.34 B140.44%
2011-12-31HK$0.14 B-42.31%
2010-12-31HK$0.24 B-25.98%
2009-12-31HK$0.33 B27.13%
2008-12-31HK$0.26 B-27.73%
2007-12-31HK$0.36 B-36.67%
2006-12-31HK$0.57 B131.48%
2005-12-31HK$0.24 B78%
2004-12-31HK$0.13 B-35.14%
2003-12-31HK$0.21 B813.99%
2002-12-31HK$23.43 M-85.01%
2001-12-31HK$0.15 B34.83%
2000-12-31HK$0.11 B2031.77%
1999-12-31HK$5.43 M-29.81%
1998-12-31HK$7.74 M-73.69%
1997-12-31HK$29.44 M52.29%
1996-12-31HK$19.33 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Agenus
AGEN
HK$26.91 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$6.62 B 11.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.91 B-67.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$1.65 B-72.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$63.69 B 972.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$116.64 B 1,864.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$75.92 B 1,178.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
HK$12.13 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$34.59 B 482.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
HK$4.54 B-23.55%๐Ÿ‡บ๐Ÿ‡ธ USA